Literature DB >> 17873159

Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).

Anthony J Alberg1, Jean G Ford, Jonathan M Samet.   

Abstract

BACKGROUND: The objective of this study was to summarize the published literature concerning the epidemiology of lung cancer.
METHODS: A narrative review of published evidence was conducted, identifying and summarizing key reports that describe the occurrence of lung cancer in populations and factors that affect lung cancer risk.
RESULTS: In the United States, lung cancer remains the leading cause of cancer death in both men and women, even though an extensive list of modifiable risk factors has long been identified. The predominant cause of lung cancer is exposure to tobacco smoke, with active smoking causing most cases but passive smoking also contributing to the lung cancer burden.
CONCLUSIONS: The reductions in smoking prevalence in men that occurred in the late 1960s through the 1980s will continue to drive lung cancer mortality rates downward in men during the first portion of this century, but rates in women have not yet begun to decrease. Fortunately, exposures to major occupational respiratory carcinogens have largely been controlled, but the population is still exposed to environmental causes of lung cancer, including radon, the second leading cause of lung cancer death.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17873159     DOI: 10.1378/chest.07-1347

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  213 in total

1.  Optical detection of buccal epithelial nanoarchitectural alterations in patients harboring lung cancer: implications for screening.

Authors:  Hemant K Roy; Hariharan Subramanian; Dhwanil Damania; Thomas A Hensing; William N Rom; Harvey I Pass; Daniel Ray; Jeremy D Rogers; Andrej Bogojevic; Maitri Shah; Tomasz Kuzniar; Prabhakar Pradhan; Vadim Backman
Journal:  Cancer Res       Date:  2010-10-05       Impact factor: 12.701

Review 2.  Parity and risk of lung cancer in women: systematic review and meta-analysis of epidemiological studies.

Authors:  Issa J Dahabreh; Thomas A Trikalinos; Jessica K Paulus
Journal:  Lung Cancer       Date:  2011-12-09       Impact factor: 5.705

3.  Down-regulation of lysyl oxidase-like 2 (LOXL2) is associated with disease progression in lung adenocarcinomas.

Authors:  Ping Zhan; Xiao-Kun Shen; Qian Qian; Ji-Ping Zhu; Yu Zhang; Hai-Yan Xie; Chuen-Hua Xu; Ke-Ke Hao; Wei Hu; Ning Xia; Guo-Jun Lu; Li-Ke Yu
Journal:  Med Oncol       Date:  2011-04-26       Impact factor: 3.064

4.  Comment on Compston: pathophysiology of atypical femoral fractures and osteonecrosis of the jaw.

Authors:  K Michaëlsson; J Schilcher; P Aspenberg
Journal:  Osteoporos Int       Date:  2012-12       Impact factor: 4.507

5.  Nanoparticle delivery of pooled siRNA for effective treatment of non-small cell lung cancer.

Authors:  Yang Yang; Yunxia Hu; Yuhua Wang; Jun Li; Feng Liu; Leaf Huang
Journal:  Mol Pharm       Date:  2012-06-22       Impact factor: 4.939

6.  Chemotherapy plus multitargeted antiangiogenic tyrosine kinase inhibitors or chemotherapy alone in advanced NSCLC: a meta-analysis of randomized controlled trials.

Authors:  Yong-Ying Xiao; Ping Zhan; Dong-Mei Yuan; Hong-Bing Liu; Tang-Feng Lv; Yong Song; Yi Shi
Journal:  Eur J Clin Pharmacol       Date:  2012-06-24       Impact factor: 2.953

7.  Personal responsibility, regret, and medical stigma among individuals living with lung cancer.

Authors:  Kevin R Criswell; Jason E Owen; Andrea A Thornton; Annette L Stanton
Journal:  J Behav Med       Date:  2015-11-06

Review 8.  [Molecular pathology of the lungs. New perspectives by next generation sequencing].

Authors:  C Vollbrecht; K König; L Heukamp; R Büttner; M Odenthal
Journal:  Pathologe       Date:  2013-02       Impact factor: 1.011

9.  The role of SOX-2 on the survival of patients with non-small cell lung cancer.

Authors:  Wenlong Shao; Hanzhang Chen; Jianxing He
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

10.  The prognostic value of osteopontin expression in non-small cell lung cancer: a meta-analysis.

Authors:  Tao Zhang; Dong-Ming Zhang; Da Zhao; Xiao-Ming Hou; Xiao-Jun Liu; Xiao-Ling Ling; Shou-Cheng Ma
Journal:  J Mol Histol       Date:  2014-05-10       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.